Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
4.880
-0.200 (-3.94%)
Nov 20, 2026, 3:00 PM CST
| Market Cap | 4.96B -40.6% |
| Revenue (ttm) | 3.83B +1.4% |
| Net Income | 157.04M -26.7% |
| EPS | 0.15 -28.2% |
| Shares Out | 1.02B |
| PE Ratio | 32.34 |
| Forward PE | 24.40 |
| Dividend | 0.06 (1.17%) |
| Ex-Dividend Date | Jul 15, 2026 |
| Volume | 6,786,419 |
| Open | 5.000 |
| Previous Close | 5.080 |
| Day's Range | 4.860 - 5.050 |
| 52-Week Range | 4.860 - 8.170 |
| Beta | 0.85 |
| Analysts | Strong Buy |
| Price Target | 7.26 (+48.83%) |
| Earnings Date | Oct 28, 2026 |